A microcosting study of immunogenicity and tumour necrosis factor alpha inhibitor drug level tests for therapeutic drug monitoring in clinical practice

Objectives. To identify and quantify resource required and associated costs for implementing TNF-α inhibitor (TNFi) drug level and anti-drug antibody (ADAb) tests in UK rheumatology practice. Methods. A microcosting study, assuming the UK National Health Service perspective, identified the direct me...

Descripción completa

Detalles Bibliográficos
Autores principales: Jani, Meghna, Gavan, Sean, Chinoy, Hector, Dixon, William G., Harrison, Beverley, Moran, Andrew, Barton, Anne, Payne, Katherine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2016
Materias:
Clinical Science
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5144665/
https://www.ncbi.nlm.nih.gov/pubmed/27576368
http://dx.doi.org/10.1093/rheumatology/kew292

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5144665/
https://www.ncbi.nlm.nih.gov/pubmed/27576368
http://dx.doi.org/10.1093/rheumatology/kew292

Ejemplares similares